TRAb (TSH Receptor Binding Antibody) is a biomarker used primarily to diagnose and manage thyroid-related disorders. It is especially useful for identifying Graves' disease, which is an autoimmune condition where the body's immune system attacks the thyroid, causing it to become overactive. TRAb testing can also help diagnose neonatal hypothyroidism, a condition in newborns where the thyroid is underactive, and postpartum thyroid dysfunction, which can occur in some women after childbirth and involves temporary thyroid problems. TRAb works by measuring antibodies in the blood that affect the thyroid-stimulating hormone (TSH) receptor. These antibodies can either stimulate or inhibit the receptor. In Graves' disease, these antibodies typically stimulate the receptor, leading to increased thyroid hormone production and symptoms like rapid heartbeat, weight loss, and anxiety. On the other hand, inhibitory antibodies can block TSH from binding to its receptor, potentially leading to reduced thyroid activity. By measuring TRAb levels, doctors can determine the presence and activity of these antibodies, providing important information about thyroid function. Managing conditions related to abnormal TRAb levels involves addressing the underlying thyroid issues. For Graves' disease, treatment options may include antithyroid medications to reduce hormone production, radioactive iodine to shrink the thyroid, or surgery to remove part or all of the thyroid gland. For neonatal hypothyroidism, hormone replacement therapy is typically required to ensure normal growth and development. In cases of postpartum thyroid dysfunction, monitoring and managing symptoms is key, as the condition often resolves on its own. Regular testing and follow-up care are important to ensure that thyroid function remains balanced and to adjust treatment as necessary.
Trans fatty acids
Trans Fatty Acid Index Includes: - Palmitelaidic (16:1n9t) - Elaidic (18:1n9t) - Linoelaidic (18:2n9t) Markedly increases the risk of heart disease by raising LDL-C and lowering HDL-C2,3 Adversely impacts serum lipid levels by:2 Decreasing rate of LDL apoB-100 clearance. Increasing rate of HDL apoA-I clearance
The marker "Trans Fatty Acids, Total" on a Nutristat Basic Profile from US Biotek measures the total amount of trans fats in a person's blood. Trans fats are a type of unsaturated fat that can be harmful to health. They are often found in processed and fried foods, as well as in baked goods made with partially hydrogenated oils. Risks Associated with High Trans Fatty Acid Levels High levels of trans fatty acids in the blood are associated with an increased risk of heart disease, as they can raise LDL (bad) cholesterol levels while lowering HDL (good) cholesterol levels. This imbalance can lead to the build-up of fatty deposits in the arteries, increasing the risk of atherosclerosis, heart attacks, and strokes. Additionally, trans fats can cause inflammation and negatively affect insulin sensitivity, contributing to the risk of diabetes. Dietary Intake and Health Implications A meta-analysis of prospective cohort studies found that a 2% increase in energy intake from trans fats was associated with a 23% increase in the incidence of coronary heart disease events and a 16% increase in coronary heart disease mortality. Another study showed that replacing 2% of energy intake from trans fats with non-hydrogenated unsaturated fats was associated with a 53% lower risk of myocardial infarction and coronary heart disease death. Monitoring and Dietary Changes Monitoring the total trans fatty acids is important for assessing dietary intake and understanding its impact on overall health. By identifying elevated levels, individuals can make dietary changes to reduce trans fat consumption, such as avoiding processed foods and choosing healthier fats, thereby improving their heart health and reducing the risk of chronic diseases.In conclusion, the marker "Trans Fatty Acids, Total" on the Nutristat Basic Profile provides valuable insights into the levels of harmful trans fats in the body. By understanding and managing these levels through dietary modifications, individuals can take proactive steps towards maintaining cardiovascular health and reducing the risk of chronic diseases associated with trans fat consumption. References: Mozaffarian, D., Katan, M. B., Ascherio, A., Stampfer, M. J., & Willett, W. C. (2006). Trans fatty acids and cardiovascular disease. New England Journal of Medicine, 354(15), 1601-1613. https://doi.org/10.1056/NEJMra054035 Hu, F. B., Stampfer, M. J., Manson, J. E., Rimm, E., Colditz, G. A., Rosner, B. A., Hennekens, C. H., & Willett, W. C. (1997). Dietary fat intake and the risk of coronary heart disease in women. New England Journal of Medicine, 337(21), 1491-1499. https://doi.org/10.1056/NEJM199711203372102 Sacks, F. M., Lichtenstein, A. H., Wu, J. H., Appel, L. J., Creager, M. A., Kris-Etherton, P. M., Miller, M., Rimm, E. B., Rudel, L. L., Robinson, J. G., Stone, N. J., & Van Horn, L. V. (2017). Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association. Circulation, 136(3), e1-e23. https://doi.org/10.1161/CIR.0000000000000510
Trans Linoleic Fatty Acid is a specific type of trans fat that is measured in the Nutristat Basic Profile by US Biotek. Trans fats, including Trans Linoleic Fatty Acid, are unsaturated fats that have been chemically altered to improve shelf life and stability in foods, but they can have negative health effects. Measuring Trans Linoleic Fatty Acid Levels On the Nutristat Basic Profile, measuring Trans Linoleic Fatty Acid levels helps assess an individual's intake of trans fats, which are commonly found in processed and fried foods. High levels of Trans Linoleic Fatty Acid in the body are a concern because they are linked to increased risks of heart disease, inflammation, and other chronic health conditions. Importance of Trans Linoleic Fatty Acid Monitoring This marker is important for understanding the impact of dietary choices on overall health. When Trans Linoleic Fatty Acid levels are high, it suggests that a person may be consuming too many unhealthy fats, which could contribute to poor cardiovascular health and metabolic disturbances. Studies have shown that a diet high in trans fats can lead to an increased risk of heart disease, stroke, and type 2 diabetes. Reducing Trans Linoleic Fatty Acid Intake By monitoring this marker, healthcare providers can offer personalized dietary recommendations to reduce trans fat intake, promoting better health outcomes. Reducing consumption of foods high in trans fats, such as baked goods, snacks, and certain margarines, can help lower Trans Linoleic Fatty Acid levels and support heart health.In conclusion, Trans Linoleic Fatty Acid is a valuable marker in the Nutristat Basic Profile that provides insights into an individual's intake of unhealthy trans fats. By monitoring and reducing Trans Linoleic Fatty Acid levels through dietary changes, individuals can take proactive steps towards improving cardiovascular health and reducing the risk of chronic diseases associated with trans fat consumption. References: Mozaffarian, D., Katan, M. B., Ascherio, A., Stampfer, M. J., & Willett, W. C. (2006). Trans fatty acids and cardiovascular disease. New England Journal of Medicine, 354(15), 1601-1613. https://doi.org/10.1056/NEJMra054035 Micha, R., & Mozaffarian, D. (2009). Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes. Nature Reviews Endocrinology, 5(6), 335-344. https://doi.org/10.1038/nrendo.2009.79 Sacks, F. M., Lichtenstein, A. H., Wu, J. H., Appel, L. J., Creager, M. A., Kris-Etherton, P. M., Miller, M., Rimm, E. B., Rudel, L. L., Robinson, J. G., Stone, N. J., & Van Horn, L. V. (2017). Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association. Circulation, 136(3), e1-e23. https://doi.org/10.1161/CIR.0000000000000510
Trans Oleic Acid is an important marker included in the Nutristat Basic Profile by US Biotek, which helps in assessing an individual's nutritional and metabolic health. Trans fats, including trans oleic acid, are a type of unsaturated fat that have been chemically altered through a process called hydrogenation. This process is often used to increase the shelf life and stability of food products. Detrimental Effects of Trans Fats However, trans fats are known to have detrimental effects on health, such as increasing the risk of heart disease by raising bad cholesterol (LDL) levels and lowering good cholesterol (HDL) levels. Trans oleic acid specifically is a trans fatty acid variant of oleic acid, which is a monounsaturated fat commonly found in foods like olive oil. While oleic acid in its natural cis form is beneficial and promotes heart health, the trans form can contribute to inflammation and other adverse health outcomes. Monitoring Trans Oleic Acid Levels Monitoring trans oleic acid levels can provide valuable insights into dietary habits, particularly the consumption of processed and fried foods, and can help guide dietary adjustments to improve overall health. High levels of trans oleic acid in the Nutristat Basic Profile indicate a need to reduce intake of trans fats and to focus on healthier fats, such as those found in nuts, seeds, avocados, and fish. Importance of Managing Trans Oleic Acid Levels Understanding and managing trans oleic acid levels is crucial for maintaining cardiovascular health and reducing the risk of chronic diseases associated with poor dietary fat quality. Studies have shown that a diet high in trans fats can lead to an increased risk of heart disease, stroke, and type 2 diabetes.In conclusion, monitoring trans oleic acid levels through the Nutristat Basic Profile is essential for assessing dietary habits and making informed choices to improve overall health. By reducing the intake of trans fats and focusing on healthier fat sources, individuals can take proactive steps towards reducing the risk of chronic diseases and promoting cardiovascular well-being. References: Mozaffarian, D., Katan, M. B., Ascherio, A., Stampfer, M. J., & Willett, W. C. (2006). Trans fatty acids and cardiovascular disease. New England Journal of Medicine, 354(15), 1601-1613. https://doi.org/10.1056/NEJMra054035 Gebauer, S. K., Chardigny, J. M., Jakobsen, M. U., Lamarche, B., Lock, A. L., Proctor, S. D., & Baer, D. J. (2011). Effects of ruminant trans fatty acids on cardiovascular disease and cancer: a comprehensive review of epidemiological, clinical, and mechanistic studies. Advances in Nutrition, 2(4), 332-354. https://doi.org/10.3945/an.111.000521 Sacks, F. M., Lichtenstein, A. H., Wu, J. H., Appel, L. J., Creager, M. A., Kris-Etherton, P. M., Miller, M., Rimm, E. B., Rudel, L. L., Robinson, J. G., Stone, N. J., & Van Horn, L. V. (2017). Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association. Circulation, 136(3), e1-e23. https://doi.org/10.1161/CIR.0000000000000510 Micha, R., & Mozaffarian, D. (2009). Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes. Nature Reviews Endocrinology, 5(6), 335-344. https://doi.org/10.1038/nrendo.2009.79
Omega-7 Fatty Acids
Omega-7 Fatty Acids
Trans-Cinnamoylglycine is one component of the Acylglycines panel. Acylglycines are an important class of metabolites that are used in the diagnosis of several organic acidurias and mitochondrial fatty acid oxidation disorders. Acylglycines are glycine conjugates of acyl-CoA species, which occur as normal intermediates of amino acid and fatty acid metabolism. In abnormal concentrations, acylglycines are biochemical markers of selected inborn errors of metabolism (IEM). Analysis of acylglycines is useful for the diagnosis and monitoring for specific fatty acid oxidation disorders and organic acidurias, although is recommended to use this testing in conjunction with urine organic acids and plasma acylcarnitines testing in order to establish a diagnosis. In particular, acylglycine analysis is more sensitive and specific for the identification of asymptomatic patients and those who may experience mild or intermittent biochemical phenotypes that could be missed by organic acid analysis alone. Diagnosis and monitoring for patients affected with 1 of the following inborn errors of metabolism: Fatty Acid Oxidation Disorders -Glutaric acidemia type II -Medium-chain 3-ketoacyl-CoA thiolase (MCKAT) deficiency -Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency -Short chain acyl-CoA dehydrogenase (SCAD) deficiency Organic Acidurias -2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (2M3HBD) deficiency -2-Methylbutyryl-CoA dehydrogenase deficiency -3-Methylcrotonyl-CoA carboxylase deficiency -3-Methylglutaconyl-CoA-hydratase deficiency -Aminoacylase 1 deficiency -Beta-ketothiolase deficiency -Ethylmalonic encephalopathy -Glutaryl-CoA dehydrogenase deficiency -Isobutyryl-CoA dehydrogenase (IBD) deficiency -Isovaleryl-CoA dehydrogenase deficiency -Multiple carboxylase deficiency -Propionic acidemia References: Costa CG, Guerand WS, Struys EA, Holwerda U, ten Brink HJ, Tavares de Almeida I, Duran M, Jakobs C. Quantitative analysis of urinary acylglycines for the diagnosis of beta-oxidation defects using GC-NCI-MS. J Pharm Biomed Anal. 2000 Jan;21(6):1215-24. doi: 10.1016/s0731-7085(99)00235-6. PMID: 10708405.
Transforming Growth Factor Beta 1 (TGF-β1) is a multifunctional cytokine playing a pivotal role in regulating a wide range of cellular processes, including cell growth, differentiation, apoptosis, and immune responses. As a member of the Transforming Growth Factor Beta superfamily of cytokines, TGF-β1 is particularly noted for its dual role in both promoting and inhibiting tumor formation. In normal physiological conditions, TGF-β1 functions as a critical regulator of tissue homeostasis, exerting potent anti-inflammatory and immunosuppressive effects. It helps maintain the balance in the immune system and prevents autoimmune responses. However, in the context of cancer, TGF-β1 has a more complex role. Initially, it acts as a tumor suppressor by inhibiting cell proliferation and inducing apoptosis. But paradoxically, in the later stages of cancer, it can promote tumor progression and metastasis by inducing epithelial-to-mesenchymal transition (EMT), angiogenesis, and immune evasion. Furthermore, TGF-β1 is involved in fibrosis and wound healing, where it stimulates the deposition of extracellular matrix components. Aberrant regulation or expression of TGF-β1 is linked to various pathological conditions, including fibrotic diseases, cardiovascular diseases, and a spectrum of cancer types. Consequently, TGF-β1 serves as a crucial biomarker and a therapeutic target, with efforts being directed towards developing TGF-β1 inhibitors for treating cancer and other diseases characterized by its dysregulation. The complexity of TGF-β1's functions underscores its significance in cellular biology and disease pathogenesis, making it a focus of extensive research in the biomedical field.
The main iron-transport protein in blood, produced by the liver.
The Transferrin Receptor, a critical protein in iron metabolism, plays a pivotal role in diagnosing and managing iron-related disorders, making it an essential biomarker in modern medical diagnostics. This receptor, found on the surface of most cells, particularly erythroblasts, binds to transferrin, the primary iron transport protein in the blood, facilitating the uptake of iron into cells. Measuring the levels of soluble transferrin receptor (sTfR) in the blood provides crucial insights into the body's iron status, especially in distinguishing between iron deficiency anemia and anemia of chronic disease. Elevated sTfR levels are typically indicative of iron deficiency, as the body increases the production of transferrin receptors to enhance iron uptake in conditions of iron scarcity. In contrast, low levels of sTfR are often seen in conditions where there is sufficient or excess iron. The transferrin receptor is particularly valuable in scenarios where traditional markers of iron status, like ferritin, may be unreliable, such as in patients with inflammation or chronic illness. Its measurement is increasingly used in conjunction with other iron parameters to give a comprehensive picture of iron homeostasis, aiding in the precise diagnosis and effective management of anemia and other iron-related disorders. The importance of the transferrin receptor in clinical practice underscores its value in advancing personalized healthcare and improving patient outcomes in hematological and iron metabolism conditions.
Percentage of transferrin bound to iron; elevated may indicate iron overload.
a multifunctional peptide growth factor
Antibodies Appear: Celiac disease